Reported Earnings • May 18
First quarter 2026 earnings released: R$0.04 loss per share (vs R$0.19 loss in 1Q 2025) First quarter 2026 results: R$0.04 loss per share (improved from R$0.19 loss in 1Q 2025). Revenue: R$37.4m (down 19% from 1Q 2025). Net loss: R$570.0k (loss narrowed 77% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. New Risk • Apr 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Brazilian stocks, typically moving 8.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.7% average weekly change). High level of non-cash earnings (20% accrual ratio). Market cap is less than US$10m (R$28.7m market cap, or US$5.76m). Minor Risk Profit margins are more than 30% lower than last year (2.5% net profit margin). Reported Earnings • Mar 31
Full year 2025 earnings released Full year 2025 results: Revenue: R$216.1m (up 7.9% from FY 2024). Net income: R$5.39m (down 48% from FY 2024). Profit margin: 2.5% (down from 5.1% in FY 2024). The decrease in margin was driven by higher expenses. Announcement • Mar 31
Nutriplant Indústria e Comércio S/A, Annual General Meeting, Apr 28, 2026 Nutriplant Indústria e Comércio S/A, Annual General Meeting, Apr 28, 2026. Location: 388 arnaldo street, bairro engenho novo, city of barueri, state of sao paulo., barueri Brazil New Risk • Feb 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Brazilian stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 24% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Market cap is less than US$10m (R$31.4m market cap, or US$6.09m). Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). New Risk • Dec 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Brazilian stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 24% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Market cap is less than US$10m (R$34.5m market cap, or US$6.24m). Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to R$2.43, the stock trades at a trailing P/E ratio of 11.9x. Average trailing P/E is 12x in the Chemicals industry in South America. Total loss to shareholders of 40% over the past year. Reported Earnings • Nov 13
Third quarter 2025 earnings released: EPS: R$0.10 (vs R$0.22 in 3Q 2024) Third quarter 2025 results: EPS: R$0.10 (down from R$0.22 in 3Q 2024). Revenue: R$54.1m (down 1.3% from 3Q 2024). Net income: R$1.39m (down 53% from 3Q 2024). Profit margin: 2.6% (down from 5.4% in 3Q 2024). The decrease in margin was primarily driven by higher expenses. New Risk • Nov 13
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.5x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 23% per year over the past 5 years. High level of non-cash earnings (20% accrual ratio). Market cap is less than US$10m (R$38.5m market cap, or US$7.29m). Minor Risk Profit margins are more than 30% lower than last year (1.2% net profit margin). Reported Earnings • Aug 13
Second quarter 2025 earnings released: EPS: R$0.043 (vs R$0.038 in 2Q 2024) Second quarter 2025 results: EPS: R$0.043 (up from R$0.038 in 2Q 2024). Revenue: R$66.2m (up 110% from 2Q 2024). Net income: R$573.0k (up 13% from 2Q 2024). Profit margin: 0.9% (down from 1.6% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. New Risk • Jul 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Brazilian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (R$37.2m market cap, or US$6.73m). Minor Risk Share price has been volatile over the past 3 months (6.9% average weekly change). Reported Earnings • May 15
First quarter 2025 earnings released: R$0.19 loss per share (vs R$0.17 profit in 1Q 2024) First quarter 2025 results: R$0.19 loss per share (down from R$0.17 profit in 1Q 2024). Revenue: R$46.3m (down 9.9% from 1Q 2024). Net loss: R$2.46m (down 212% from profit in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Reported Earnings • Mar 31
Full year 2024 earnings released: EPS: R$0.78 (vs R$0.27 in FY 2023) Full year 2024 results: EPS: R$0.78 (up from R$0.27 in FY 2023). Revenue: R$200.3m (up 12% from FY 2023). Net income: R$10.3m (up 193% from FY 2023). Profit margin: 5.1% (up from 2.0% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Announcement • Mar 31
Nutriplant Indústria e Comércio S/A, Annual General Meeting, Apr 29, 2025 Nutriplant Indústria e Comércio S/A, Annual General Meeting, Apr 29, 2025. Location: 388 arnaldo street, bairro engenho novo, city of barueri, stateofsao paulo, barueri Brazil Valuation Update With 7 Day Price Move • Dec 02
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to R$3.89, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 10x in the Chemicals industry in South America. Total loss to shareholders of 8.5% over the past year. Reported Earnings • Nov 14
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: R$54.8m (down 3.6% from 3Q 2023). Net income: R$2.95m (up 123% from 3Q 2023). Profit margin: 5.4% (up from 2.3% in 3Q 2023). The increase in margin was driven by lower expenses. Valuation Update With 7 Day Price Move • Nov 13
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to R$3.35, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 9x in the Chemicals industry in South America. Total loss to shareholders of 17% over the past year. New Risk • Oct 29
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: R$55.6m (US$9.74m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 17
Second quarter 2024 earnings released: EPS: R$0.038 (vs R$0.002 loss in 2Q 2023) Second quarter 2024 results: EPS: R$0.038 (up from R$0.002 loss in 2Q 2023). Revenue: R$31.5m (down 27% from 2Q 2023). Net income: R$508.0k (up R$525.0k from 2Q 2023). Profit margin: 1.6% (up from 0% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 28
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to R$5.51, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 10x in the Chemicals industry in Brazil. Total returns to shareholders of 130% over the past three years. Reported Earnings • May 18
First quarter 2024 earnings released: EPS: R$0.17 (vs R$0.017 in 1Q 2023) First quarter 2024 results: EPS: R$0.17 (up from R$0.017 in 1Q 2023). Revenue: R$51.4m (up 85% from 1Q 2023). Net income: R$2.19m (up R$1.97m from 1Q 2023). Profit margin: 4.3% (up from 0.8% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 26% per year, which means it is well ahead of earnings. Reported Earnings • Mar 31
Full year 2023 earnings released: EPS: R$0.26 (vs R$0.63 in FY 2022) Full year 2023 results: EPS: R$0.26 (down from R$0.63 in FY 2022). Revenue: R$179.1m (up 2.4% from FY 2022). Net income: R$3.51m (down 58% from FY 2022). Profit margin: 2.0% (down from 4.8% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to R$6.70, the stock trades at a trailing P/E ratio of 23.2x. Average trailing P/E is 10x in the Chemicals industry in Brazil. Total returns to shareholders of 139% over the past three years. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to R$4.74, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 11x in the Chemicals industry in Brazil. Total returns to shareholders of 58% over the past year. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment improves as stock rises 109% After last week's 109% share price gain to R$9.00, the stock trades at a trailing P/E ratio of 31.1x. Average trailing P/E is 13x in the Chemicals industry in Brazil. Total returns to shareholders of 307% over the past three years. Reported Earnings • Nov 08
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: R$56.9m (up 18% from 3Q 2022). Net income: R$1.32m (up 30% from 3Q 2022). Profit margin: 2.3% (up from 2.1% in 3Q 2022). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Sep 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to R$3.69, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 13x in the Chemicals industry in Brazil. Total returns to shareholders of 98% over the past three years. New Risk • Aug 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: R$49.6m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (R$49.6m market cap, or US$9.99m). Minor Risk Profit margins are more than 30% lower than last year (2.3% net profit margin). Reported Earnings • Aug 09
Second quarter 2023 earnings released: R$0.001 loss per share (vs R$0.25 profit in 2Q 2022) Second quarter 2023 results: R$0.001 loss per share (down from R$0.25 profit in 2Q 2022). Revenue: R$43.3m (down 23% from 2Q 2022). Net loss: R$17.0k (down 100% from profit in 2Q 2022). Profit margin: 0% (down from 5.8% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance. Reported Earnings • May 10
First quarter 2023 earnings released: EPS: R$1.65 (vs R$0.14 in 1Q 2022) First quarter 2023 results: EPS: R$1.65. Revenue: R$27.8m (down 19% from 1Q 2022). Net income: R$219.0k (down 87% from 1Q 2022). Profit margin: 0.8% (down from 5.1% in 1Q 2022). The decrease in margin was driven by lower revenue. Board Change • May 04
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Commercial Director & Director Mario Croffi was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jan 28
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). CEO, Financial & Investor Relations Officer and Director Ricardo Lessa Pansa was the last director to join the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Aug 11
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: R$55.8m (up 79% from 2Q 2021). Net income: R$3.26m (up 64% from 2Q 2021). Profit margin: 5.8% (down from 6.4% in 2Q 2021). The decrease in margin was driven by higher expenses. Board Change • Aug 09
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). CEO, Financial & Investor Relations Officer and Director Ricardo Lessa Pansa was the last director to join the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 05
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. No independent directors (3 non-independent directors). CEO, Financial & Investor Relations Officer and Director Ricardo Lessa Pansa was the last director to join the board, commencing their role in 2009. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.